BidaskClub downgraded shares of Masimo (NASDAQ:MASI) from a buy rating to a hold rating in a research report report published on Saturday, BidAskClub reports.

Other equities analysts have also issued reports about the stock. UBS Group upped their price objective on shares of Masimo from $207.00 to $245.00 and gave the stock a buy rating in a report on Thursday, April 30th. Stifel Nicolaus upped their price objective on shares of Masimo from $200.00 to $245.00 and gave the stock a buy rating in a report on Wednesday, April 29th. Raymond James upgraded shares of Masimo from a market perform rating to an outperform rating and set a $183.00 price objective on the stock in a report on Monday, March 2nd. Needham & Company LLC lowered shares of Masimo from a buy rating to a hold rating in a report on Monday, April 20th. Finally, ValuEngine lowered shares of Masimo from a buy rating to a hold rating in a report on Friday, May 1st. Four analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. Masimo has a consensus rating of Buy and a consensus price target of $208.33.

NASDAQ:MASI opened at $227.99 on Friday. The firm has a market capitalization of $11.89 billion, a price-to-earnings ratio of 61.79, a PEG ratio of 3.19 and a beta of 0.91. The company’s 50-day moving average is $231.24 and its two-hundred day moving average is $191.19. Masimo has a 1-year low of $139.36 and a 1-year high of $258.00.

Masimo (NASDAQ:MASI) last issued its quarterly earnings data on Tuesday, April 28th. The medical equipment provider reported $0.97 EPS for the quarter, topping the consensus estimate of $0.91 by $0.06. Masimo had a net margin of 21.66% and a return on equity of 17.05%. The firm had revenue of $269.63 million for the quarter, compared to analyst estimates of $268.40 million. During the same period in the prior year, the business posted $0.79 EPS. The business’s revenue for the quarter was up 16.4% compared to the same quarter last year. Sell-side analysts anticipate that Masimo will post 3.14 EPS for the current year.

In other Masimo news, Director Adam Mikkelson sold 1,498 shares of the stock in a transaction that occurred on Monday, June 8th. The shares were sold at an average price of $216.01, for a total value of $323,582.98. Following the sale, the director now directly owns 2,802 shares of the company’s stock, valued at approximately $605,260.02. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director H Michael Cohen sold 587 shares of the stock in a transaction that occurred on Thursday, June 4th. The shares were sold at an average price of $225.37, for a total transaction of $132,292.19. Following the completion of the sale, the director now directly owns 717 shares in the company, valued at $161,590.29. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 351,114 shares of company stock worth $68,294,418. 11.50% of the stock is owned by company insiders.

Several large investors have recently made changes to their positions in the business. Altshuler Shaham Ltd increased its position in shares of Masimo by 91.0% in the 1st quarter. Altshuler Shaham Ltd now owns 170 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 81 shares during the last quarter. Sumitomo Mitsui Trust Holdings Inc. increased its position in shares of Masimo by 3.4% in the 1st quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 2,754 shares of the medical equipment provider’s stock valued at $488,000 after purchasing an additional 90 shares during the last quarter. Utah Retirement Systems increased its position in shares of Masimo by 1.1% in the 4th quarter. Utah Retirement Systems now owns 9,021 shares of the medical equipment provider’s stock valued at $1,426,000 after purchasing an additional 100 shares during the last quarter. Flagship Harbor Advisors LLC increased its position in shares of Masimo by 29.8% in the 1st quarter. Flagship Harbor Advisors LLC now owns 436 shares of the medical equipment provider’s stock valued at $77,000 after purchasing an additional 100 shares during the last quarter. Finally, Janney Montgomery Scott LLC increased its position in shares of Masimo by 1.7% in the 1st quarter. Janney Montgomery Scott LLC now owns 6,131 shares of the medical equipment provider’s stock valued at $1,086,000 after purchasing an additional 102 shares during the last quarter. 84.48% of the stock is currently owned by institutional investors.

About Masimo

Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.

Featured Article: Yield Curve

Analyst Recommendations for Masimo (NASDAQ:MASI)

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.